CRRTF - Crescita Therapeutics GAAP EPS of C$0.04 revenue of C$7.56M March, 23 2022 08:25 AM Coronet Carpets Inc Crescita Therapeutics press release (OTC:CRRTF): Q4 GAAP EPS of C$0.04. Revenue of C$7.56M (+171.0% Y/Y). For further details see: Crescita Therapeutics GAAP EPS of C$0.04, revenue of C$7.56M